WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Inc Stock Ownership - Who owns Arcutis Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcutis Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Howard G. WelgusDirector2026-04-0110,000$23.88
$238.80kSell
Masaru MatsudaReporting Persons title EVP Chief Legal Officer2026-03-026,553$25.16
$164.87kSell
Howard G. WelgusDirector2026-03-0210,000$25.65
$256.52kSell
Masaru MatsudaReporting Persons title EVP Chief Legal Officer2026-03-02193$25.91
$5.00kSell
Masaru MatsudaReporting Persons title EVP Chief Legal Officer2026-03-021,987$25.70
$51.07kSell
Keith R. LeonardDirector2026-03-0239,272$25.39
$997.19kSell
Keith R. LeonardDirector2026-03-0212,220$7.51
$91.77kBuy
Todd WatanabeReporting Persons title President and Chief Executive Officer2026-03-021,068$25.91
$27.68kSell
Keith R. LeonardDirector2026-03-0227,052$8.63
$233.46kBuy
Latha VairavanSVP Chief Financial Officer2026-03-022,772$25.16
$69.74kSell

1 of 11

ARQT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARQT insiders and whales buy or sell their stock.

ARQT Shareholders

What type of owners hold Arcutis Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Heron15.67%19,430,454$477.41MInsider
Suvretta Capital Management LLC9.65%11,964,000$293.96MInstitution
Frazier Life Sciences Management LP7.96%9,874,511$242.62MInstitution
Blackrock Inc7.34%9,099,579$223.58MInstitution
Frazier Life Sciences VIII LP7.13%8,838,534$217.16MInsider
Rubric Capital Management LP6.67%8,271,577$203.23MInstitution
Vanguard Group Inc5.85%7,253,936$178.23MInstitution
Jennison Associates LLC5.45%6,758,006$166.04MInstitution
Polar Capital Holdings PLC4.48%5,556,169$136.52MInstitution
State Street Corp4.42%5,488,301$134.85MInstitution

1 of 3

ARQT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARQT77.21%22.79%Net SellingNet Selling
CPRX84.18%15.82%Net Selling
DNLI63.03%36.97%Net Selling
ORKA25.56%74.44%Net BuyingNet Selling
ALMS62.16%23.09%Net Buying
View Top Biotech Stocks

Arcutis Biotherapeutics Stock Ownership FAQ

Who owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics (NASDAQ: ARQT) is owned by 104.46% institutional shareholders, 30.84% Arcutis Biotherapeutics insiders, and 0.00% retail investors. Patrick J. Heron is the largest individual Arcutis Biotherapeutics shareholder, owning 19.43M shares representing 15.67% of the company. Patrick J. Heron's Arcutis Biotherapeutics shares are currently valued at $470.41M.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.